Author name: Peplife Research

Selank research: how this tuftsin analogue is studied in studies for anxiety, stress and cognition via GABA and BDNF routes. RUO.

Epitalon research: the AEDG tetrapeptide studied for telomerase, melatonin and ageing. A sober look at the evidence, RUO.

MOTS-C research: how this mitochondrial-derived peptide is studied for AMPK activation, insulin sensitivity, metabolism and ageing, plus data limits. RUO.

Melanotan 2 research: how this melanocortin agonist drives melanogenesis and pigmentation, plus the difference with melanotan 1. RUO, not approved.

What does GHK-Cu research show? How the copper peptide is studied in laboratory studies for collagen, skin rejuvenation and wound healing. RUO.

CJC-1295 research: the GHRH mechanism, the difference between DAC and no-DAC, and the combination with ipamorelin. RUO.

Ipamorelin research: how this selective GH secretagogue and ghrelin receptor agonist stimulates GH release in preclinical studies. RUO.

Overview of semaglutide research: the GLP-1 mechanism and the studies SUSTAIN, STEP and SELECT. Solely for in-vitro laboratory research (RUO).

Tirzepatide research explained: how the dual GIP/GLP-1 agonist works and what the SURPASS and SURMOUNT studies reported. RUO — for laboratory research.

Retatrutide (LY3437943) is a triple GLP-1/GIP/glucagon agonist. What research shows about fat loss and metabolism — RUO, HPLC-tested.